Intradermal botulinum A toxin injection for axillary hyperhydrosis
Authors:
- Marie-Klaire FarrugiaMFMarie-Klaire Farrugia
- Eric A. NichollsENEric A. Nicholls
- 1 October 2005
- journal article
- case report
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 40 (10) , 1668-1669
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treating childhood hyperhidrosis with botulinum toxin type AArchives of Disease in Childhood, 2002
- Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Equinus Foot Deformity in Cerebral Palsy: A Multicenter, Open-Label Clinical TrialPediatrics, 2001
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trialBMJ, 2001
- Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticityDevelopmental Medicine & Child Neurology, 2001
- Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)New England Journal of Medicine, 2001
- A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosisBritish Journal of Dermatology, 1999
- The role of botulinus toxin type A in treatment – with special reference to childrenBrain and Development, 1999
- DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1Movement Disorders, 1997
- Complications in Patients with Palmar Hyperhidrosis Treated with Transthoracic Endoscopic SympathectomyNeurosurgery, 1997
- Biology of sweat glands and their disorders. II. Disorders of sweat gland functionJournal of the American Academy of Dermatology, 1989